- ONC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
BeiGene (ONC) 8-K8 Dec 20Zanubrutinib was shown to be highly active in patients with relapsed/refractory marginal zone lymphomaFinancial data
Company Profile